Strategy shaped by the people redefining the science.
We connect you directly to the specialists shaping your therapeutic area — and structure their insight into strategy you can act on. Biomarkers, competitive landscapes, regulatory pathways, and the journey from lab to clinic.
Discuss Your Challenge →Your strategy, shaped by the people who know.
Avrion orchestrates direct access to the specialists working in your therapeutic area — and structures their expertise into strategic guidance you can act on. No desk research. No generalists. The people who actually design studies, navigate approval, and shape treatment decisions.
We bring together diagnostic developers, assay specialists, and regulatory experts to inform your biomarker strategy — assessing technical feasibility, approval pathways, and commercial viability through structured expert consultation.
Understand diagnostic approaches across development and adoption through direct input from scientists, regulatory specialists, and diagnostics professionals — not secondary sources alone.
Structured engagement with specialists who bridge the gap between discovery and clinic. Study design considerations, development landscape analysis, and strategic direction informed by practitioners who've navigated the path.
Pipeline priorities, competitive positioning, and market opportunity — informed by direct engagement with specialists who understand both the science and the commercial reality of drug development.
Primary intelligence on where your therapy fits. Competitive positioning, unmet needs, and clinical reality gathered through structured specialist engagement — adding depth that published literature alone cannot provide.
We design, recruit, and facilitate advisory boards tailored to your programme. The right specialists, the right questions, structured to deliver actionable strategic input on your timeline.
The Network Behind the Advice
Avrion has no labs and no in-house scientists — by design. Instead, every engagement draws on Ayesda Bio's specialist network: thousands of verified professionals including discovery scientists, regulatory specialists, medical affairs leaders, market access experts, and practising clinicians.
These are established, maintained relationships — not cold outreach. The specialists we engage design studies, navigate regulatory approval, shape commercial strategy, and inform treatment decisions every day. We structure that expertise into consultations, advisory boards, and strategic programmes that give you actionable insight.
- Established access to specialists across therapeutic areas
- Advisory boards designed, recruited, and facilitated end-to-end
- Primary insight from active practitioners, not desk research
- KOL identification and structured engagement
- Ongoing expert relationships that deepen over time
Avrion doesn't work in isolation. When your advisory engagement surfaces a question that needs quantitative validation, Connect's primary research capability is already there. And both draw on the same panel of 5,000+ verified life sciences professionals. One operation — expert access and market intelligence, working together.